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The antibacterial activity of methanol, ethanol, chloroform, and hexane extracts of the leaves
of Himalayan gymnospermous plant Ginkgo biloba L. was assessed against ﬁve animal and
plant pathogenic strains (Agrobacterium tumefaciens, Bacillus subtilis, Escherichia coli, Erwinia
chrysanthemi, and Xanthomonas phaseoli) employing disc-diffusion and broth-dilution assays.
The methanol extract showed the highest activity (zone of inhibition of 15–21mm) followed by
ethanol (14–19mm), chloroform (15–20mm), and hexane (14–19mm) extracts at 250µg/mL. A
minimum inhibitory concentration (MIC) of 7.8µg/mL was found for the methanol extract against
most of the pathogens tested.
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1. INTRODUCTION
Ginkgo biloba L. is considered a living fossil due to its survival over millions of years [1, 2]. One of
the greatest properties of Ginkgo is its resistance to serious plant diseases. Ginkgo contains a number of
biologically active compounds for its defence against insects, bacteria, and fungi [3]. An extract from the
leaves of G. biloba, used in the treatment of cerebral insufﬁciency, was developed in the 1960s [4]a n d
designated EGb 761. This preparation is an acetone-water (60:40) extract from the dried leaves [5]. A
number of secondary metabolites, like terpenoids, polyphenols, organic acids, and amino acids have been
isolated from the plant. However, the main bioactive constituents are terpene trilactones and ﬂavonoid
glycosides which are considered responsible for the pharmacological activities of the standardized leaf
extract [6]. Ginkgo leaves have attracted much attention as agents for improving cerebral circulation and
they possess antitumor, antiparasitic, and antiviral activities [7–9]. The role of the extract in the treatment
of diseases involving free radicals and oxidative damage has also been suggested [10, 11].
However, little is known about the antimicrobial activity of gymnospermous plants including G.
biloba [12]. Therefore, the antibacterial potential of various crude organic extracts of leaves of G. biloba
collected at high altitude in Kumaun Himalaya, India was evaluated against a wide range of pathogenic
bacterial strains.
2. MATERIALS AND METHODS
2.1. Collection of Plant Material
T h et r e eo fGinkgo biloba (Ginkgoaceae) or maidenhair tree (Figure 1(a)) is characterized by fan-shaped
leaves and ﬂeshy, yellow, foul-smelling seeds, enclosing a silvery, edible inner kernel. The green leaves of
G. biloba (Ginkgoaceae) were collected in the month of June 2010 from Nainital, Kumaun Himalaya, India
and authenticated by the Department of Botany, Kumaun University, Nainital. A voucher specimen was
deposited in the herbarium of the department (KU 203).
2.2. Extraction Procedure
Leaves of the plant were thoroughly washed and dried at room temperature. The dried material was
powdered in an electric grinder (Figure 1(b)). To prepare a stock solution, 50g of this powder was added to
200mL of solvents (w/v, 50g/200mL). Solvents used for extraction were methanol, ethanol, chloroform,
hexane, and water. Each extract was shaken for at least 6h and after that each extract was passed through
Whatman ﬁlter paper no.1. The ﬁnal ﬁltrate was concentrated on a rotary evaporator under vacuum at 20◦C
and was utilized for the experiments.
2.3. Microorganisms Used
Five (Gram +ve and −ve) bacteria (Bacillus subtilis MTCC no.121, Escherichia coli MTCC no.40,
Agrobacterium tumefaciens MTCC no.609, borrowed from Institute of Microbial Technology, Chandigarh,
India and Xanthomonas phaseoli and Erwinia chrysanthemi were obtained from Plant Pathology Depart-
ment, G. B. Pant University, Pantnagar, India) were used.
2.4. Screening of Antibacterial Activity
Antibacterial tests of selected microorganisms were carried out using a disc-diffusion method [13]. A small
sterile cotton swab was dipped into the 24-hour-old culture of bacteria and was inoculated by streaking the
swab over the entire agar surface. After inoculation the plates were allowed to dry at room temperature in
laminar chamber. The ﬁlter paper discs (5mm) loaded with 40µL of extract were placed on the surface of
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FIGURE 1: (a) Ginkgo biloba; (b) leaves powder.
the agar plates. After 5min the plates were incubated at 37◦C for 24h. Gentamycin (30mg), erythromycin
(15mg), and ampicillin (10mg; Central Drug House Ltd., New Delhi) were used as positive controls and
the respective solvent as negative control. After 24h of incubation, the diameter was observed for zone of
inhibition, ZOI (measured in mm including disc size). All tests were performed in triplicate and observed
values of ZOI are expressed as mean value with standard error of means (SEM).
2.5. Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal
Concentration (MBC)
All the fractions were tested for the minimum inhibitory concentration and minimum bactericidal
concentration. MIC was performed at ﬁve concentrations of extracts (125, 62.5, 31.25, 15.62, 7.81µg/mL)
following serial dilution technique. All the wells showing no visible growth of microorganisms were
subcultured and incubated at 37◦C overnight. The highest dilution showing 100% inhibition was recorded
as MBC.
3. RESULTS AND DISCUSSION
3.1. Results
The antibacterial activity of G. biloba methanol, ethanol, chloroform, and hexane extracts against
microorganisms were examined in the present study and their potency were quantitatively assessed by
ZOI (Table 1), MIC, and MBC values (Table 2). The results indicated that the methanol extract showed the
highest activity among all the tested extracts and inhibited the growth of all the bacterial strains (Table 1).
MIC and MBC values for the microorganisms sensitive to the methanol extract were in the range of 7.8–
15.62µg/mL and 31.25–62.5µg/mL, respectively (Table 2). The ethanol and chloroform extracts showed
MIC and MBC values in the same range. For the hexane extract, the MIC values were in the range of 15.62–
31.25µg/mL and MBC were 62.5–125µg/mL. It was interesting to note that all the fractions were found
more active than the used standard antibiotics (Figure 2).
3.2. Discussion
G. biloba, a high altitude grown Kumaun Himalayan plant has not been studied for its antibacterial activity.
Therefore, the present study highlights for the ﬁrst time the in vitro antibacterial activities of different
solvent fractions of this plant.
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FIGURE 2: Inhibition zones (in mm) observed in methanol, ethanol, chloroform, and hexane extracts as
compared to ampicillin, erythromycin, and gentamycin. Bar represents standard errors and mean value of
inhibition zone.
TABLE 1: Zone of inhibition of different extracts of Ginkgo biloba.
Microorganisms
Diameter of inhibition zone (mm)∗
HCEM E A G
A. tumefaciens 16 ± 0.8 19 ± 0.6 14 ± 1.0 15 ± 0 n an a2 0 ± 0.6
B. subtilis 20 ± 1.7 18 ± 01 9 ± 0.6 19 ± 0 . 6n an a2 0 ± 0.4
E. coli 15 ± 01 4 ± 0.3 19 ± 1.0 19 ± 0 . 6n an a2 1 ± 1.2
E. chrysanthemi 16 ± 0.5 17 ± 0.8 16 ± 0.6 17 ± 0 . 3n an a2 1 ± 1.2
X. phaseoli 16 ± 0.8 16 ± 0.6 19 ± 1.0 21 ± 0 . 2n an a2 1 ± 0.7
∗All the values are mean ± SEM of three determinations. H, C, E, M: hexane, chloroform, ethanol, methanol; E, A, G: erythromycin, ampicillin,
gentamycin; na: not active.
The present data show that there is no uniform response between bacterial strains studied in terms
of susceptibility in all these crude extract of G. biloba (Table 1). Our ﬁndings show that small amounts of
crude extracts of Ginkgo leaves (7.8µg/mL) possess inhibitory activity against Gram-positive and Gram-
negative bacteria. The present investigation supports the ethnobotanical uses of G. biloba. Relying upon [6]
terpene trilactones and ﬂavonoid glycosides, the active compounds of Ginkgo biloba might be responsible
for its antimicrobial potential.
This study also provides new leads as there are no previous records on the antibacterial activity of G.
biloba extracts against the plant pathogenic strains X. phaseoli, A. tumefaciens, and E. chrysanthemi.
This is the ﬁrst report to demonstrate the antibacterial potential of ethanol, chloroform, and hexane
extracts of G. biloba. These results also conﬁrm the evidences in previous studies that methanol is a better
solvent to extract antimicrobial substances from medicinal plants [14–16]. This study provides a strong
scientiﬁc basis for the ethnomedical use of G. biloba against bacterial diseases of animals and plants.
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TABLE 2: Minimum inhibitory/bactericidal concentration (µg/mL).
Microorganisms
MIC and MBC values (µg/mL)
HC E M
A. tumefaciens
31.25 15.62 31.25 7.81
∗125 ∗31.25 ∗62.25 ∗31.25
B. subtilis
15.62 7.81 7.81 7.81
∗62.5 ∗31.25 ∗15.25 ∗31.25
E. coli
15.62 31.25 31.25 15.62
∗125 ∗62.5 ∗62.5 ∗31.25
E. chrysanthemi
15.62 15.62 31.25 15.62
∗62.5 ∗62.5 ∗62.25 ∗62.5
X. phaseoli
31.25 15.62 15.62 7.81
∗62.5 ∗31.25 ∗62.25 ∗62.5
∗MBC values.
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